Injectable Nanodevices Exhibit Potency Against Brain Tumors
A new nano-sized injectable technology developed at the MIT Media Lab has shown striking results against one of medicine's toughest cancers. In lab tests, it wiped out just over half of the malignant cells in samples from patients whose tumors had stopped responding to standard drugs, a kill rate roughly five times higher than a common chemotherapy agent. Called HITMAN, the device performed just as well in animal testing. Mice given the treatment lived roughly half again as long as untreated animals, with no detected harm to organs including the lungs, liver, or heart. The count of newly formed cancer…

